XML 67 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Assumptions Used
The Company did not grant options or employee stock purchase rights during the three months ended December 31, 2014 and 2013. The fair values of the options and employee stock purchase rights granted during the nine months ended December 31, 2014 and 2013 are estimated as of the grant date using the Black-Scholes option-pricing model with the following weighted-average assumptions:
 
Options
 
Employee Stock Purchase Rights
 
Nine months ended December 31,
 
Nine months ended December 31,
 
2014
 
2013
 
2014
 
2013
Expected life (years)
*
 
4.4

 
0.5

 
0.5

Risk-free interest rate
*
 
0.6
%
 
0.1
%
 
0.1
%
Volatility
*
 
49
%
 
57
%
 
57
%
Dividend yield
*
 
%
 
%
 
%
Weighted average fair value
*
 
$
2.95

 
$
2.57

 
$
3.67


* The Company did not grant options during the nine months ended December 31, 2014.
Summary of Stock-Based Compensation Expense of Stock Options and Restricted Stock Units
The following table summarizes stock-based compensation expense related to stock options and RSUs (in thousands):
 
 
 
Three Months Ended
Nine Months Ended
 
 
December 31,
December 31,
 
 
2014
 
2013
2014
 
2013
Stock-based compensation expense by type of grant:
 
 
 
 
 
 
 
Stock options
 
$
454

 
$
648

$
1,160

 
$
1,987

RSUs
 
4,428

 
5,231

13,148

 
11,454

 
 
4,882

 
5,879

14,308

 
13,441

Stock-based compensation expensed from (capitalized to) inventory
 
(25
)
 
3

(5
)
 
(11
)
Total stock-based compensation expense
 
$
4,857

 
$
5,882

$
14,303

 
$
13,430

Summary of Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense as it relates to the Company’s Condensed Consolidated Statement of Operations (in thousands):
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
December 31,
 
December 31,
 
 
2014
 
2013
 
2014
 
2013
Stock-based compensation expense by cost centers:
 
 
 
 
 
 
 
 
Cost of revenues
 
$
97

 
$
118

 
$
226

 
$
353

Research and development
 
2,992

 
1,545

 
9,039

 
4,867

Selling, general and administrative
 
1,793

 
4,216

 
5,043

 
8,221

 
 
$
4,882

 
$
5,879

 
$
14,308

 
$
13,441

Stock-based compensation expensed from (capitalized to) inventory
 
(25
)
 
3

 
(5
)
 
(11
)
Total stock-based compensation expense
 
$
4,857

 
$
5,882

 
$
14,303

 
$
13,430